ABIRATERONE TEVA 500 mg, film-coated tablet 60 tablets
Active ingredients: Abiraterone, Abiraterone acetate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet60 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ABIRATERONE TEVA 500 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 60 plaquettes unitaires prédécoupées PVC polychlortrifluoroéthylène PVC-Aluminium de 1 comprimé(s)
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 9 Sept 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63001674CIP73025430CIP133400930254301Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACÉTATE D'ABIRATÉRONEcomprimé | 500 mg · un comprimé | SA |
| ABIRATÉRONEcomprimé | 446,3 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.